A detailed history of Cwm, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Cwm, LLC holds 5,291 shares of NUVB stock, worth $12,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,291
Previous 1,094 383.64%
Holding current value
$12,380
Previous $3,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.3 - $3.83 $9,653 - $16,074
4,197 Added 383.64%
5,291 $12,000
Q2 2024

Jul 09, 2024

BUY
$2.58 - $3.69 $2,801 - $4,007
1,086 Added 13575.0%
1,094 $3,000
Q1 2024

Apr 05, 2024

BUY
$1.46 - $3.97 $11 - $31
8 New
8 $0
Q2 2023

Aug 03, 2023

BUY
$1.56 - $1.84 $524 - $618
336 New
336 $1,000
Q3 2022

Oct 27, 2022

BUY
$0.29 - $4.04 $271 - $3,777
935 Added 1798.08%
987 $2,000
Q2 2022

Jul 28, 2022

BUY
$3.24 - $5.85 $168 - $304
52 New
52 $0

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $508M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.